
Sign up to save your podcasts
Or


Netflix falls on concerns over slowing subscriber growth. United Health reports healthy earnings. And Johnson & Johnson rises on strong pharmaceutical sales.
Analysts Andy Cross and Jason Moser discuss those stories. Thanks to Harry’s for supporting Motley Fool. Get your Trial Set – go to Harrys.com/fool .
By The Motley Fool4.7
16041,604 ratings
Netflix falls on concerns over slowing subscriber growth. United Health reports healthy earnings. And Johnson & Johnson rises on strong pharmaceutical sales.
Analysts Andy Cross and Jason Moser discuss those stories. Thanks to Harry’s for supporting Motley Fool. Get your Trial Set – go to Harrys.com/fool .

3,223 Listeners

1,500 Listeners

806 Listeners

951 Listeners

521 Listeners

1,178 Listeners

2,168 Listeners

826 Listeners

1,417 Listeners

1,040 Listeners

9,627 Listeners

192 Listeners

809 Listeners

76 Listeners

40 Listeners

988 Listeners

44 Listeners